申请人:American Cyanamid Company
公开号:US04347251A1
公开(公告)日:1982-08-31
This disclosure describes novel 3-substituted amino-1-substituted heteroaryl-2-pyrazolines and their C.sub.4 and C.sub.5 analogs, effective as agents that ameliorate inflammation, analgesic agents, antibacterial agents and/or anti-fungal agents.
这份披露描述了新颖的3-取代氨基-1-取代杂环-2-吡唑啉和它们的C.sub.4和C.sub.5类似物,作为减轻炎症、镇痛剂、抗菌剂和/或抗真菌剂的药物。